Preconditioning during simulated MIDCABG attenuates blood flow defects and neutrophil accumulation

Annals of Thoracic Surgery

Volumn 66, Issue 3, 1998, Pages 726-731

  Bufkin, Bradley L ^a   Shearer, Steven T ^a   Vinten Johansen, Jakob ^a,b   Duarte, Ignacio G ^a   Thourani, Vinod H ^a   Nakamura, Masanori ^a   Zhao, Zhi Qing ^a   Guyton, Robert A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Carlyle Fraser Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DOG; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE WALL MOTION; HEMODYNAMICS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MINIMALLY INVASIVE SURGERY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SIMULATION;

EID: 0032167461     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00529-3     Document Type: Article

References (24)

1. 1. Bolli R, Triana F, Jeroudi MO. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury. Clin Cardiol 1989;12 (Suppl 3):16-25.
2. 2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
3. 3. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263: H1107-12.
4. 4. Lawson CS, Hearse DJ. Ischemic preconditioning against arrhythmias: an anti-arrhythmic or an anti-ischemic phenomenon? Ann NY Acad Sci 1994;723:138-57.
5. 5. Ovize M, Przyklenk K, Hale SL, Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation 1992;85: 2247-54.
6. 6. Sato H, Zhao Z-Q, McGee DS, Williams MW, Hammon JW Jr, Vinten-Johansen J. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 1995;110:302-14.
7. 7. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993;88:2337-50.
8. 8. Bufkin BL, Mellitt RJ, Gott JP, Huang AH, Chih P, Guyton RA. Aerobic blood cardioplegia for revascularization of acute infarct: effects of delivery temperature. Ann Thorac Surg 1994;58:953-60.
9. 9. Miura T, Iimura O. Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine. Cardiovasc Res 1993;27:36-42.
10. 10. Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992;86:986-94.
11. 1-receptors. Circulation 1992;86:1310-6.
12. 12. Thourani VH, Nakamura M, Duarte IG, et al. Ischemic preconditioning attenuates postischemic coronary artery endothelial dysfunction in a model of minimally invasive direct coronary artery bypass (MIDCAB) [Abstract]. J Thorac Cardiovasc Surg (in press).
13. 13. DeFily DV, Chilian WM. Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am J Physiol 1993;265:H700-6.
14. 14. Bauer B, Simkhovisch BZ, Kloner RA, Przyklenk K. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury? Circulation 1993;88: 659-72.
15. 15. Calafiore AM, Di Giammarco G, Teodori G. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg 1996;61:1658-65.
16. 16. Manciet LH, Poole DC, McDonagh PF, Copeland JG, Mathieu-Costello O. Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon. Am J Physiol 1994;266:H1541-50.
17. 17. Schmid-Schönbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987;46:2397-401.
18. 18. Ma X-L, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-12.
19. 19. Dreyer WJ, Michael LH, West MW, et al. Neutrophil accumulation in ischemic canine myocardium: insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 1991;84:400-11.
20. 20. Mullane K. Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc Med 1991;1:282-9.
21. 21. Bolli R. Role of neutrophils in myocardial stunning after brief ischaemia: the end of a six year old controversy (1987-1993) [Comment]. Cardiovasc Res 1993;27:728-30.
22. 22. Wallace A. Do deficiencies of endothelial derived relaxing factor contribute to myocardial stunning? [Review]. J Cardiol Surg 1993;8:325-8.
23. 23. Williams MW, Taft CS, Ramnauth S, Zhao Z-Q, Vinten-Johansen J. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 1995;30:79-86.
24. 24. Vinten-Johansen J, Zhao Z-Q. Cardioprotection from ischemic-reperfusion injury by adenosine. In: Abd-Elfattah AS, Wechsler AS, eds. Purines and myocardial protection. Norwell: Kluwer Academic Publishers, 1995:315-44.